[Frailty and kidney transplant candidates].

La fragilidad en candidatos a trasplante renal.

Journal

Nefrologia
ISSN: 2013-2514
Titre abrégé: Nefrologia (Engl Ed)
Pays: Spain
ID NLM: 101778581

Informations de publication

Date de publication:
Historique:
received: 08 06 2020
revised: 25 08 2020
accepted: 07 09 2020
pubmed: 20 12 2020
medline: 4 1 2022
entrez: 19 12 2020
Statut: ppublish

Résumé

Frailty is a concept that has been mainly developed in geriatrics and it came from the need of identifying subjects at risk to develop complications when they faced a stressful event. Frail patients have higher risk of mortality, poor outcomes and disability, and this is independent from their age or comorbidities. Chronic kidney disease patients present with high prevalence of frailty, especially those who are in renal replacement therapy. Frail or pre-frail patients on the kidney transplant waiting list represent 20-30%, and these patients are proven to have poorer results after the transplant, which is a stressful event itself. Tools for frailty assessment, both scales or indexes, may be useful to identify which subjects might be at risk for complications after transplant, and this is necessary to adapt our clinical practice and minimize morbidity. The most used frailty scale in kidney patients is Fried scale, which is based in five phenotypic items. Besides that, knowing frail population allows potential interventions such as prehabilitation while the patient is waiting for the kidney transplant, which the aim of improving their vulnerability prior to transplant and, therefore, optimizing results after transplant. More studies are needed amongst kidney patients to improve and prevent frailty.

Identifiants

pubmed: 33339673
pii: S0211-6995(20)30178-8
doi: 10.1016/j.nefro.2020.09.004
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng spa

Sous-ensembles de citation

IM

Pagination

237-243

Informations de copyright

Copyright © 2020 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

María José Pérez-Sáez (MJ)

Servicio de Nefrología, Hospital del Mar, Barcelona, España. Electronic address: mjoseperezsaez@gmail.com.

Álex Gutiérrez-Dalmau (Á)

Servicio de Nefrología, Hospital Universitario Miguel Servet, Zaragoza, España.

Francesc Moreso (F)

Servicio de Nefrología, Hospital Universitario Vall d'Hebron, Barcelona, España.

Leocadio Rodríguez Mañas (L)

Servicio de Geriatría, Hospital Universitario de Getafe, Madrid, España.

Julio Pascual (J)

Servicio de Nefrología, Hospital del Mar, Barcelona, España.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH